Skip navigation
Skip navigation

LPHN3 and attention-deficit/hyperactivity disorder: A susceptibility and pharmacogenetic study

Bruxel, E. M.; Salatino-Oliveira, A.; Akutagava-Martins, G. C.; Tovo-Rodrigues, L.; Genro, J. P.; Zeni, C. P.; Polanczyk, G. V.; Chazan, R.; Schmitz, M.; Arcos-Burgos, Mauricio; Rohde, L. A.; Hutz, M. H.


Latrophilin 3 (LPHN3) is a brain-specific member of the G-protein coupled receptor family associated to both attention-deficit/hyperactivity disorder (ADHD) genetic susceptibility and methylphenidate (MPH) pharmacogenetics. Interactions of LPHN3 variants with variants harbored in the 11q chromosome improve the prediction of ADHD development and medication response. The aim of this study was to evaluate the role of LPHN3 variants in childhood ADHD susceptibility and treatment response in a...[Show more]

CollectionsANU Research Publications
Date published: 2015
Type: Journal article
Source: Genes, Brain and Behavior
DOI: 10.1111/gbb.12224


File Description SizeFormat Image
01_Bruxel_LPHN3_and_2015.pdf239.04 kBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  19 May 2020/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator